Hoffman William's Form 4 filing
Inari Medical, Inc.NARI · filed Sep 19, 2023
- Accession no.
- 0001127602-23-024441
- Filed
- Sep 19, 2023
- Trade date
- Sep 15, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $1.67M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Common Stock | SSaleDisposed | −7,099 | $66.40F2 | −$471,373.6 | 1,040,956 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −7,901 | $67.05F3 | −$529,762.05 | 1,033,055 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −3,229 | $66.27F4 | −$213,985.83 | 1,029,826 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −6,671 | $66.95F5 | −$446,623.45 | 1,023,155 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −100 | $67.58 | −$6,758 | 1,023,055 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $65.73 to $66.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $66.74 to $67.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $65.57 to $66.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $66.57 to $67.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.